Explore how health innovation can improve lives, strengthen economies and unlock socioeconomic value, with new WifOR research, supported by Roche, on breast cancer, multiple sclerosis and retinal diseases.
Prof Loveday’s perspective on recognising the early signs of Alzheimer’s disease and how an early diagnosis, memory strategies and planning ahead helped her mother live well with Alzheimer’s.
Three diseases. One mission. Roche combines breakthrough technologies with deep immunology expertise and real-world data to transform treatment for lupus, IBD, and COPD
AMR threatens modern medicine. Learn how Roche is advancing novel antibiotics, diagnostics and partnerships to fight drug-resistant bacterial infections.
Explore evolving Alzheimer's diagnostic options. Learn how blood biomarker technology innovations like pTau217 are replacing uncertainty with timely clarity for patients and clinicians.
Roche at the World Health Summit 2026. As global health leaders gather in Berlin for the World Health Summit 2026, we have a vital opportunity to address a fundamental question: how do we shift healthcare from being treated as a short-term budget line to a primary driver of economic stability?
The 2026 Ophtha Innovation Challenge (OIC) seeks scalable solutions to improve DME care in underserved regions, alongside global initiatives to optimize Real-World Evidence (RWE) ecosystems.
Discover how Roche and Genentech's new Boston Innovation Center combines CVRM research, AI, and Harvard collaboration to develop transformative medicines for patients
The World Cancer Congress 2026 advances global cancer care through flexible models, early detection, and equity. Roche’s diagnostics and medicines offer a full perspective from detection to ongoing care.
Explore how HPV self-collection gives OB-GYNs new options to screen underserved patients, overcome care barriers, and advance cervical cancer elimination.